265 related articles for article (PubMed ID: 29483670)
1. Novel variants in Nordic patients referred for genetic testing of telomere-related disorders.
Norberg A; Rosén A; Raaschou-Jensen K; Kjeldsen L; Moilanen JS; Paulsson-Karlsson Y; Baliakas P; Lohi O; Ahmed A; Kittang AO; Larsson P; Roos G; Degerman S; Hultdin M
Eur J Hum Genet; 2018 Jun; 26(6):858-867. PubMed ID: 29483670
[TBL] [Abstract][Full Text] [Related]
2. Genetic analyses of aplastic anemia and idiopathic pulmonary fibrosis patients with short telomeres, possible implication of DNA-repair genes.
Arias-Salgado EG; Galvez E; Planas-Cerezales L; Pintado-Berninches L; Vallespin E; Martinez P; Carrillo J; Iarriccio L; Ruiz-Llobet A; Catalá A; Badell-Serra I; Gonzalez-Granado LI; Martín-Nalda A; Martínez-Gallo M; Galera-Miñarro A; Rodríguez-Vigil C; Bastos-Oreiro M; Perez de Nanclares G; Leiro-Fernández V; Uria ML; Diaz-Heredia C; Valenzuela C; Martín S; López-Muñiz B; Lapunzina P; Sevilla J; Molina-Molina M; Perona R; Sastre L
Orphanet J Rare Dis; 2019 Apr; 14(1):82. PubMed ID: 30995915
[TBL] [Abstract][Full Text] [Related]
3. The relationship between DNA methylation and telomere length in dyskeratosis congenita.
Gadalla SM; Katki HA; Shebl FM; Giri N; Alter BP; Savage SA
Aging Cell; 2012 Feb; 11(1):24-8. PubMed ID: 21981348
[TBL] [Abstract][Full Text] [Related]
4. Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita.
Alter BP; Baerlocher GM; Savage SA; Chanock SJ; Weksler BB; Willner JP; Peters JA; Giri N; Lansdorp PM
Blood; 2007 Sep; 110(5):1439-47. PubMed ID: 17468339
[TBL] [Abstract][Full Text] [Related]
5. TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements.
Du HY; Pumbo E; Ivanovich J; An P; Maziarz RT; Reiss UM; Chirnomas D; Shimamura A; Vlachos A; Lipton JM; Goyal RK; Goldman F; Wilson DB; Mason PJ; Bessler M
Blood; 2009 Jan; 113(2):309-16. PubMed ID: 18931339
[TBL] [Abstract][Full Text] [Related]
6. Advances in the understanding of dyskeratosis congenita.
Walne AJ; Dokal I
Br J Haematol; 2009 Apr; 145(2):164-72. PubMed ID: 19208095
[TBL] [Abstract][Full Text] [Related]
7. The effect of TERC haploinsufficiency on the inheritance of telomere length.
Goldman F; Bouarich R; Kulkarni S; Freeman S; Du HY; Harrington L; Mason PJ; Londoño-Vallejo A; Bessler M
Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17119-24. PubMed ID: 16284252
[TBL] [Abstract][Full Text] [Related]
8. TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes.
Walne AJ; Vulliamy T; Beswick R; Kirwan M; Dokal I
Blood; 2008 Nov; 112(9):3594-600. PubMed ID: 18669893
[TBL] [Abstract][Full Text] [Related]
9. Differences in disease severity but similar telomere lengths in genetic subgroups of patients with telomerase and shelterin mutations.
Vulliamy TJ; Kirwan MJ; Beswick R; Hossain U; Baqai C; Ratcliffe A; Marsh J; Walne A; Dokal I
PLoS One; 2011; 6(9):e24383. PubMed ID: 21931702
[TBL] [Abstract][Full Text] [Related]
10. [Bone marrow failure due to telomere associated gene mutation].
Yamaguchi H; Dan K
Rinsho Ketsueki; 2010 Aug; 51(8):646-53. PubMed ID: 20805671
[No Abstract] [Full Text] [Related]
11. Pulmonary fibrosis in dyskeratosis congenita: a case report with a PRISMA-compliant systematic review.
Wang P; Xu Z
BMC Pulm Med; 2021 Sep; 21(1):279. PubMed ID: 34479523
[TBL] [Abstract][Full Text] [Related]
12. Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita.
Parry EM; Alder JK; Lee SS; Phillips JA; Loyd JE; Duggal P; Armanios M
J Med Genet; 2011 May; 48(5):327-33. PubMed ID: 21415081
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and genetic features of dyskeratosis congenital with bone marrow failure in eight patients].
Wan Y; An WB; Zhang JY; Zhang JL; Zhang RR; Zhu S; Chang LX; Zhang YC; Liu F; Yang WY; Chen XJ; Zou Y; Chen YM; Zhu XF
Zhonghua Xue Ye Xue Za Zhi; 2016 Mar; 37(3):216-20. PubMed ID: 27033759
[TBL] [Abstract][Full Text] [Related]
14. High resolution melting analysis for the identification of novel mutations in DKC1 and TERT genes in patients with dyskeratosis congenita.
Carrillo J; Martínez P; Solera J; Moratilla C; González A; Manguán-García C; Aymerich M; Canal L; Del Campo M; Dapena JL; Escoda L; García-Sagredo JM; Martín-Sala S; Rives S; Sevilla J; Sastre L; Perona R
Blood Cells Mol Dis; 2012 Oct 15-Dec 15; 49(3-4):140-6. PubMed ID: 22664374
[TBL] [Abstract][Full Text] [Related]
15. Exogenous TERC alone can enhance proliferative potential, telomerase activity and telomere length in lymphocytes from dyskeratosis congenita patients.
Kirwan M; Beswick R; Vulliamy T; Nathwani AC; Walne AJ; Casimir C; Dokal I
Br J Haematol; 2009 Mar; 144(5):771-81. PubMed ID: 19036115
[TBL] [Abstract][Full Text] [Related]
16. A pathogenic dyskerin mutation impairs proliferation and activates a DNA damage response independent of telomere length in mice.
Gu BW; Bessler M; Mason PJ
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10173-8. PubMed ID: 18626023
[TBL] [Abstract][Full Text] [Related]
17. Acute telomerase components depletion triggers oxidative stress as an early event previous to telomeric shortening.
Ibáñez-Cabellos JS; Pérez-Machado G; Seco-Cervera M; Berenguer-Pascual E; García-Giménez JL; Pallardó FV
Redox Biol; 2018 Apr; 14():398-408. PubMed ID: 29055871
[TBL] [Abstract][Full Text] [Related]
18. Comparable Effects of the Androgen Derivatives Danazol, Oxymetholone and Nandrolone on Telomerase Activity in Human Primary Hematopoietic Cells from Patients with Dyskeratosis Congenita.
Vieri M; Kirschner M; Tometten M; Abels A; Rolles B; Isfort S; Panse J; Brümmendorf TH; Beier F
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003434
[TBL] [Abstract][Full Text] [Related]
19. Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells.
Donaires FS; Alves-Paiva RM; Gutierrez-Rodrigues F; da Silva FB; Tellechea MF; Moreira LF; Santana BA; Traina F; Dunbar CE; Winkler T; Calado RT
Stem Cell Res; 2019 Oct; 40():101540. PubMed ID: 31479877
[TBL] [Abstract][Full Text] [Related]
20. Editing TINF2 as a potential therapeutic approach to restore telomere length in dyskeratosis congenita.
Choo S; Lorbeer FK; Regalado SG; Short SB; Wu S; Rieser G; Bertuch AA; Hockemeyer D
Blood; 2022 Aug; 140(6):608-618. PubMed ID: 35421215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
